+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Esomeprazole Market 2020-2026

  • PDF Icon


  • June 2020
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 5129653
Global Esomeprazole Market Size, Share & Trends Analysis Report, By Disease (Erosive Esophagitis, Gastroesophageal Reflux Disease, Helicobacter Pylori Infection, Other), By Type (Branded and Generic), By Dosage Type (Capsules & Tablets, Injections, and Other) and Forecast, 2020-2026
The global esomeprazole market is anticipated to show a modest growth rate during the forecast period 2020-2026. Esomeprazole was first approved by the US FDA to AstraZeneca plc under the brand name Nexium. High incidences of gastroesophageal reflux disease (GERD) is one of the major factors for the growth of the market all across the globe. In 2017, esomeprazole was prescribed around 9 million times alone in the US. However, prescription numbers are reducing continuously since 2011. The presence of alternative drugs of esomeprazole is one of the major restraining factors for market growth. Omeprazole, a chemical isomer of esomeprazole is one of the most common alternatives of esomeprazole.

The global esomeprazole market is segmented based on disease, type, and dosage type. By disease, the market is further segmented into erosive esophagitis, gastroesophageal reflux disease, helicobacter pylori infection, and others. By type, the market is bifurcated into branded and generic drugs. Significant growth in the generic drug market will be witnessed during the forecast period all across the globe. By dosage type, the market is segmented into capsules & tablets, injections, and others. Capsules & tablets are expected to have a major market share during the forecast period.

By geography, the global esomeprazole market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to hold a considerable market share. However, significant major market growth will be witnessed in Asia-Pacific due to significant revenue generation of Nexium in Japan and China.

The esomeprazole market is consolidated in nature and a few major market players are operating in the market. Some of the major market players include AbbVie Inc, Sanofi SA, Mylan NV, Novartis AG, Teva Pharmaceutical Industries Ltd., Grünenthal GmbH, Glenmark Pharmaceuticals Inc., and Mylan N.V. The market players are adopting growth strategies including mergers & acquisitions, product approvals, and partnerships & collaborations to gain a competitive edge in the market.

Research Methodology

The market study of the global esomeprazole market is incorporated by extensive primary and secondary research. Secondary research has been conducted to breakdown the market in various segments; derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts to amplify the added validity of the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:
  • Global Esomeprazole Market Research and Analysis, By Disease
  • Global Esomeprazole Market Research and Analysis, By Type
  • Global Esomeprazole Market Research and Analysis, By Dosage Type

The Report covers:
  • Comprehensive research methodology of the Global Esomeprazole Market.
  • A detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global Esomeprazole Market.
  • Insights about market determinants which are stimulating the Global Esomeprazole Market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdowns
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. AbbVie Inc Overview Financial Analysis SWOT Analysis Recent Developments
3.3.2. Sanofi SA Overview Financial Analysis SWOT Analysis Recent Developments
3.3.3. Mylan NV Overview Financial Analysis SWOT Analysis Recent Developments
3.3.4. Novartis AG Overview Financial Analysis SWOT Analysis Recent Developments
3.3.5. Teva Pharmaceutical Industries Ltd. Overview Financial Analysis SWOT Analysis Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities
5. Market Segmentation
5.1. Global Esomeprazole Market by Disease
5.1.1. Erosive Esophagitis
5.1.2. Gastroesophageal Reflux Disease
5.1.3. Helicobacter Pylori Infection
5.1.4. Other
5.2. Global Esomeprazole Market by Type
5.2.1. Branded
5.2.2. Generic
5.3. Global Esomeprazole Market by Dosage Type
5.3.1. Capsules & Tablets
5.3.2. Injections
5.3.3. Other ( Suspension)
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Alkem Laboratories Ltd.
7.2. AstraZeneca plc
7.3. Aurobindo Pharma Ltd.
7.4. Cadila Healthcare Ltd.
7.5. Chongqing LUMMY Pharmaceutical Co., Ltd.
7.6. Dr. Reddy’s Laboratories Ltd.
7.7. Glenmark Pharmaceuticals Inc.
7.8. Grünenthal GmbH
7.9. Laboratorios Saval S.A.
7.10. Lannett Co., Inc.
7.11. Mylan N.V
7.12. Novartis AG (Sandoz)
7.13. Sanofi SA
7.14. Stada Arzneimittel AG
7.15. Sun Pharmaceutical Industries Ltd.
7.16. Teva Pharmaceutical Industries Ltd.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Alkem Laboratories Ltd.
  • AstraZeneca plc
  • Aurobindo Pharma Ltd.
  • Cadila Healthcare Ltd.
  • Chongqing LUMMY Pharmaceutical Co., Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Glenmark Pharmaceuticals Inc.
  • Grünenthal GmbH
  • Laboratorios Saval S.A.
  • Lannett Co., Inc.
  • Mylan N.V
  • Novartis AG (Sandoz)
  • Sanofi SA
  • Stada Arzneimittel AG
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.